Teladoc Health jumps after third-quarter revenue beats estimates

By Reuters News

** Shares of telehealth firm Teladoc Health TDOC.N rise 9.4% to $7.53 in extended trading

** Posts Q3 revenue of $605.10 million, above analysts' estimates of $588.5 million, according to data compiled by LSEG

** Company expects 2026 revenue in the range of $2.40 billion to $2.44 billion compared with analysts estimates of $2.41 billion

** Expects Q4 revenue in the range of $569 million to $615 million versus estimates of $597.39 million

** Stock down 1.7% YTD, as of last close

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.